Paydirt
Insider filing · RVMD

Mark A Goldsmith sold $3.9M of Revolution Medicines (RVMD)

Executed Nov 1 2024, disclosed Nov 5 2024, 4 days later.

Value, as filed
$3.9M
70,000 sh across 4 lots
Executed
Nov 1 2024
the trade date, as filed
Disclosed
Nov 5 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
MG Mark A Goldsmith See Remarks profile →

Mark A Goldsmith (See Remarks) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $18.0M of RVMD (120,000 sh × $150.09, as filed), executed Apr 15.

The name
RVMD Revolution Medicines, Inc. RVMD · Healthcare · 80 filings in 24 months ticker →

Healthcare · Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Mark A Goldsmith in RVMD
RVMDSALE Revolution Medicines, Inc. $2.7M
13,775 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:02 PM ET RVMDSALE Revolution Medicines, Inc. $17.7M
84,644 sh across 10 lots
Exec Aug 21
Filed Aug 25 · 4:06 PM ET RVMDSALE Revolution Medicines, Inc. $1.6M
10,020 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $18.0M
120,000 sh × $150.09
Exec Apr 15
Filed Apr 17 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $1.3M
12,871 sh × $99.48
Exec Mar 17
Filed Mar 19 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $3.3M
32,249 sh across 5 lots
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $1.2M
15,394 sh × $76.82
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. $5.0M
66,000 sh across 3 lots
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET